European Journal of Pharmacology · 2023 · 28 citations · 33 references
Life SciencesBiochemistryPharmacologyCell SignalingMetabolic RegulationMetabolismHepatic PathophysiologyLipid MetabolismLiver DiseaseLiver PhysiologyMetabolic Liver DiseaseGut Microbiota DysbiosisHepatic Lipid AccumulationHepatic Lipid MetabolismHepatic Metabolic ResponseLipid Metabolism EffectsLipid Metabolism PathwaysPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated Receptors
33
DADA2: High-resolution sample inference from Illumina amplicon data
Benjamin J. Callahan, Paul J. McMurdie, Michael Rosen et al. · Nature Methods · 2016 · 36.3K citations
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin, Yingrui Li, Zhiming Cai et al. · Nature · 2012 · 7K citations · Full text
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Chengyu Jiang, Adrian T. Ting, Brian Seed · Nature · 1998 · 2.9K citations
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Peter Tontonoz, László Nagy, Jacqueline G. Alvarez et al. · Cell · 1998 · 1.8K citations · Full text